Houston, TX -- (SBWIRE) -- 06/18/2018 -- The Global Smart Insulin Pens Market is accounted for $58 million in 2016 and expected to grow at a CAGR of 12.2% to reach $130 million by 2023. Factors influencing the market growth are concerns for continuous glucose monitoring, introducing devices with smart connectivity and increasing diabetic patient pool. In addition, demand for personalized or patient centric devices and preventing the needle stick injury provide opportunity for the market. However, blood sugar control is the most challenging aspect as well as security concern and high costs of smart pens are restraining the market growth.

Based on type, Bluetooth connected smart insulin pens logs injected insulin doses directly to the patient's digital blood glucose through the Bluetooth wireless interface. The software records each dose accurately and transfers readings into MRAM and waits for activation of the Bluetooth Smart radio. If, the insulin delivery data doesn't transfer to the phone then, it's stored in the pen, gets ready for the next attempt as soon as the capacitor is recharged. Bluetooth Smart SoC is a unique and effective concept for insulin delivery pens. The pen has combination with other electronic tools, which can lead to glucose control accessible and affordable, which in turn assists in reducing complications and helps patients lead longer lives. BULE (or Bluetooth Smart) technology provides secure 128-bit encrypted data transfer capabilities.

For Sample Copy of this Report: https://www.researchnreports.com/request_sample.php?id=53929

North America dominated the smart insulin pens market owing to high persistence of obsolete syringe technology and rising prevalence of diabetes. However, Asia Pacific is the fastest growing market due to increase in prevalence with age and provides new treatment opportunities.

Some of the key players in the Global Smart Insulin Pens market are Companion Medical Inc, Digital Medics Ptd Ltd, Eli Lilly and Company, Novo Nordisk A/S, DIAMESCO, Roche, Insulet, Cardiocomm Solutions, BioSampling, Megasan Medical, Emperra GmbH E-Health Technologies, Nipro, Jiangsu Delfu medical device Co.,Ltd and Sanofi Diabetes.

Usabilities Covered:
- Reusable Pens
- Pre-Filled Pens

Indications Covered:
- Diabetes Type I
- Diabetes Type II

Types Covered:
- Second Generation Pens
- First Generation Pens

Distribution Channels Covered:
- Ambulatory Surgical Centers
- Home Care Settings
- Hospitals & Clinics
- Retail Pharmacies
- e-Commerce

Fabrications Covered:
- Plastic
- Metal

Technologies Covered:
- Bluetooth
- Jet Injectors
- Spring loaded

Avail Discount on this report: https://www.researchnreports.com/ask_for_discount.php?id=53929

This market report is a thorough analysis of the existing situation and the anticipated condition for Smart Insulin Pens market. Investigation for gathering the content for this report is done in depth and meticulously. Present scenarios, past progress, global recognition and future prospects of Smart Insulin Pens market is offered in this report. Main strategies, market shares, products of the companies and investments in Smart Insulin Pens market is also mentioned in detail.
The major geographical regions which include, North America, Asia Pacific, Europe, the Middle East & Africa and Latin America are studied. Top manufacturers from all these regions are studied to help give a better picture of the market investment. Production, price, capacity, revenue and many such important data is been discussed with precise data.
Compressive outline of Smart Insulin Pens market depending on key factors and segmentations such as end users, applications, regions and products is elaborated. Estimated revenue and volume growth of Smart Insulin Pens market over the mentioned forecast period of 2017 to 2023 is also explained in detail. Former and current state of shares of the major key regions are mentioned such that the idea of the best investment region can be drawn out.